HIV associated nephropathy: A treatable condition

Sexually Transmitted Infections

Volumn 77, Issue 2, 2001, Pages 97-100

  Brook, M G ^a   Miller, R F ^b  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

HAART; HIV; Nephropathy

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; DOSE CALCULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; MEDICAL INFORMATION; PRIORITY JOURNAL; PROTEINURIA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 0035060734     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.77.2.97     Document Type: Article

References (52)

1. Acute renal failure in the course of HIV infection: A single-institution retrospective study of ninety-two patients and sixty renal biopsies
2. Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS
3. Virus de l'immunodeficience humaine et insuffisance renale aigue
4. Acute renal failure syndromes in human immunodeficiency virus infection
5. Renal lesions in AIDS: A biopsy and autopsy study
6. Renal pathology and HIV infection in Thailand
7. Renal lesions associated with AIDS - An autopsy study
8. Renal pathology of human immunodeficiency virus infection
9. Outcome of severe renal failure in patients with acquired immunodeficiency syndrome
10. Renal manifestations of concurrent systemic lupus erythematosus and HIV infection
11. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection
12. Changes in renal function associated with indinavir
13. HIV-associated nephropathy
14. HIV-associated nephropathy: Outcome and prognostic factors
15. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy
16. Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington DC area: 12 years' experience
17. Pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy
18. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection
19. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy
20. Human immunodeficiency virus-associated nephropathy in the Bronx: Low prevalence in a predominantly Hispanic population
21. AIDS and HIV infection in the United Kingdom: Monthly report
22. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators
23. Estimating the population impact in Australia of improved anti-retroviral treatment for HIV infection
24. CD4 cell counts in adults with newly diagnosed HIV infection: Result of surveillance in England and Wales 1990-1998
25. As HIV related deaths fall, increased numbers need treatment
26. Diagnostic sonography of HIV-associated nephropathy: New observations and clinical correlation
27. Enhanced proliferation, apoptosis, and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice
28. Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy
29. Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytes
30. Increased levels of transforming growth factor-β in HIV-associated nephropathy
31. Tubular cell and HIV-1 gp120 interaction products promote migration of monocytes
32. HIV-1 gp120 envelope protein and morphine-tubular cell interaction products modulate kidney fibroblast proliferation
33. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy
34. Presentation, diagnosis and management of renal failure in patients with HIV infection
35. HIV-1-assocated nephropathy and response to highly-active antiretroviral therapy
36. Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube
37. Treatment of human immunodeficiency virus (HIV)-associated nephropathy
38. Captopril and renal survival with human immunodeficiency virus nephropathy
39. Clinical response to prolonged corticosteroids in a patient with human immunodeficiency virus-associated nephropathy
40. AIDS-associated membranous nephropathy with advanced renal failure: Response to prednisolone
41. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy
42. One-center experience with cyclosporine in refractory nephrotic syndrome in children
43. Prevalence de l'infection a VIH chez les patients dialyses: Resultats d'une enquete multicentrique nationale
44. Maintenance haemodyalisis in patients with HIV-associated nephropathy
45. Management of antiretroviral therapy
46. Single dose plasma profiles of abacavir (1592-ABC) in renal failure
47. Disposition and biotransformantion of the antiretroviral drug nevirapine in humans
48. Characterisation of the in vitro biotransformation of HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450
49. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection
50. Antiviral therapy for HIV patients with renal insufficiency